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The influence of aortic cuffs and iliac limb
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Background: In a proportion of patients with an endovascular abdominal aortic aneurysm repair (EVAR), aortic cuffs or
iliac graft limb extensions are required to enhance sealing or to fix the position of the device. This requirement arises when
these goals are not primarily obtained with the basic stent-graft configuration. The aim of this study was to assess the
influence of the use of endograft extensions during the primary EVAR procedure on the short- and long-term outcome.
Methods: The study was based on the data of the EUROSTAR registry. Patient and anatomic characteristics, data
regarding the procedure, postoperative complications, and the mortality of patients undergoing EVAR were retrieved
from the database. Patients were divided into three groups: (1) no extensions, (2) proximal aortic cuffs, and (3) iliac limb
extensions. Logistic regression and Cox proportional hazards models were used to compare significant influences of the
use of cuffs or extensions on different outcomes relative to control patients, adjusted for patient and anatomic factors.
Results: The overall cohort comprised 6668 patients: 4932 (74.0%) without extensions, 259 (3.9%) with an aortic cuff,
and 1477 (22.2%) with an iliac endograft extension. Both the 30-day (2.3%-3.9%) and the all-cause mortality rates
(23%-27% at 4 years) were similar in the three study groups. The use of proximal cuffs or iliac extensions did not have an
effect on the incidence of endoleaks of any type (24%-32% at 4 years). The incidences of device kinking (P  .0344) and
secondary transfemoral interventions (P  .0053) during follow-up were increased in patients in whom iliac limb
extensions were used. In patients with aortic cuffs, no significant associations with altered outcome were observed.
Conclusions: The use of iliac graft limb extensions at EVAR was associated with a higher incidence of kinking and
secondary transfemoral interventions, whereas proximal aortic cuffs did not influence outcome. (J Vasc Surg 2007;45:
79-85.)Elective endovascular repair (EVAR) of an abdominal
aortic aneurysm (AAA) is an accepted interventional alter-
native to open aortic repair. Randomized clinical trials
demonstrated a lower initial mortality rate compared with
open repair.1-4 In a considerable number of patients, com-
plete exclusion is not obtained with the basic endograft
combination, typically consisting of a body piece and uni-
lateral or bilateral iliac limb endografts. In addition to these
two- or three-piece devices, one of the current brands
markets a unipiece model. In cases in which aneurysmal
disease of the iliac arteries is present, a multijunctional graft
containing one or more graft limb extensions is sometimes
needed to reach the external iliac artery for safe sealing. In
other cases, inaccurate preoperative size or length measure-
ments of aneurysm morphology necessitate an endograft
extension. Finally, sealing may be incomplete at the site of
proximal or distal attachment because of calcifications,
resulting in endoleakage. Proximal aortic cuffs or distal iliac
graft limb extensions have been demonstrated to be helpful
for achieving successful stent grafting.5 In some patients,
multiple graft extensions may be needed to obtain com-
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may reduce the need for stent-graft extensions. In a study
by Velazquez et al,6 fewer iliac graft limb extensions were
required when software-assisted three-dimensional recon-
struction based on computed tomography (CT) was used.
However, in the day-to-day practice of many centers, these
advanced imaging techniques are not the routine.
An endograft that is composed of multiple parts is more
complex and presumably has a greater risk of device-related
complications.7 Furthermore, the use of graft extensions
prolongs the procedure, and this may be associated with a
greater incidence of procedure- or patient-related compli-
cations. Most studies concerning endograft extensions de-
scribe their application during secondary interventions.5,8
Little is known about the relationship between the use of
aortic cuffs and iliac extensions during the primary proce-
dure and the effects on long-term outcome. The objective
of this study was to assess whether the use of endograft
extensions influences the early or late outcomes of EVAR of
AAAs.
MATERIALS AND METHODS
Perioperative data of 6668 patients from 167 centers in
19 countries were retrieved from the European collaborators
on stent-graft techniques for AAA repair (EUROSTAR) reg-
istry.9,10 This voluntary registry was founded in 1996 with
the objective of collecting data on EVAR of AAAs. Several
commercially available stent grafts were used, including 47
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January 200780 Hobo, Laheij, and ButhAnaconda (Sulzer Vascutek Ltd, Inchinnan, Scotland), 924
AneuRx (Medtronic Corp, Santa Rosa, Calif), 915 Ex-
cluder (Gore Inc, Flagstaff, Ariz), 71 EVT (Guidant Inc,
Menlo Park, Calif), 84 Fortron (Cordis/Johnson & John-
son, Fort Lauderdale, Fla), 127 Lifepath (Edwards Life-
sciences, Irvine, Calif), 123 Powerlink (Endologix, Irvine,
Calif), 1855 Talent (Medtronic), and 2522 Zenith (Cook
Inc, Bloomington, Ind). Vanguard and Stentor stent grafts
were initially enrolled into the EUROSTAR registry but have
been excluded from recent analyses together with EVT de-
vices enrolled before June 1, 1998. The purpose of this was to
obtain study outcomes representative of the current situation.
Eligible patients with EVAR of a nonruptured, asymptomatic
AAAwere prospectively enrolled into the registry on an inten-
tion-to-treat basis to prevent selection bias. Informed con-
sent was obtained. From 2002, most patient data were
entered online into the EUROSTAR database at the Web
site http://www.eurostar-online.org (KIKA Medical,
Nancy, France). Alternatively, contributing physicians
could complete a printed standardized case record form for
submission to the data registry center by fax or mail. In this
study, the 3-year follow-up was 74% complete for all pa-
tients expected to have a 3-year follow-up.
Sex, age, American Society of Anesthesiologists class,
risk factors according to the Society for Vascular Surgery/
International Society for Cardiovascular Surgery guide-
lines,11 aneurysm morphology assessed by enhanced CT
and angiography, procedural technical details, and postop-
erative outcomes (including mortality, endoleaks, compli-
cations, secondary interventions, and ruptures) were re-
corded. All patients had a maximum aneurysm diameter of
at least 40mm, and patients with missing operative data were
excluded from analysis. Furthermore, patients without any
follow-up were excluded from the analysis. Follow-up find-
ings at clinical examination and CT assessment and, in a
small proportion, angiography, magnetic resonance imag-
ing, or duplex ultrasonography were recorded at 1, 3, 6, 12,
18, and 24 months after surgery and annually thereafter.
Patients who underwent operation up to December 2005
were enrolled in this study.
Study group assignment was based on the use of aortic
cuffs or iliac graft limb extensions only during the primary
stent-graft procedure. The first cohort consisted of patients
without any graft extension. The second cohort of patients
had a proximal aortic cuff, and the third cohort included
patients who had an iliac graft limb extension device. Some
patients required both a proximal aortic cuff and an iliac
limb extension. In this analysis, these patients were assigned
to the cohort of proximal aortic cuffs. Postoperative out-
come was compared among these three groups. Early pro-
cedural and clinical outcome events included 30-day mor-
tality, rupture, and conversion rate. Cardiac, neurologic,
gastroenterologic, and renal complications were assessed,
combined, and indicated as systemic complications. Late
postoperative outcome events involved device migration,
stenosis, thrombosis, kinking (a collapse of the stent graft
caused by excessive bending), endoleaks, aneurysm rupture,
aneurysmal growth (defined as an 8-mm increase from thepreoperative measurement), the need for secondary interven-
tions (subdivided into transfemoral, extra-anatomic, and con-
version to open aortic repair), and all-cause and aneurysm-
related mortality. Aneurysm-related mortality was defined
as death within 30 days of the initial or any secondary aortic
intervention or that associated with aneurysm rupture or
endograft infection. Reporting was in accordance with the
guidelines of the ad hoc Committee for Standardized Re-
porting Practices in Vascular Surgery of the Society for
Vascular Surgery/American Association for Vascular Sur-
gery.12
Chi-square tests, Mann-Whitney tests, and multivariate
logistic regression were performed for procedural out-
comes, and Kaplan-Meier life tables and Cox proportional
hazards models were used for late outcomes of proximal
aortic cuffs and iliac limb extensions compared with
endografts without any additional extension. Resulting
P values were adjusted for confounding variables, includ-
ing patient-related (age, sex, and risk factors), anatomic
(dimensions, angulations, iliac aneurysmal disease, and oc-
clusive disease), procedural (type of stent graft), and phy-
sician-related (team experience) factors. A P value .05
implied statistical significance. Statistical analysis was per-
formed with the SAS system (version 8.02; SAS Institute,
Cary, NC).
RESULTS
The study group consisted of 6668 patients out of a
total of 10,146 enrolled into the EUROSTAR database,
with a mean age of 72.4 years (range, 43-100 years).
Patients were enrolled between October 1996 and Decem-
ber 2005, and the mean follow-up period was 21.3 months
(range, 0-108 months). Three groups were distinguished:
group 1 (4932 patients; 74.0%), who did not require any
additional endograft extension; group 2 (259 patients;
3.9%), who had an aortic cuff; and group 3 (1477 patients;
22.2%), who had an iliac graft limb extension. Patients with
iliac graft limb extensions were older than the control
group (72.9 vs 72.2 years; P  .0037), had more frequent
hyperlipemia (47.1% vs 43.5%; P  .0143) and renal co-
morbidities (21.0% vs 17.6%; P  .0036), and were more
frequently unfit for open repair (27.9% vs 24.8%; P 
.0174) compared with the control group (Table I). Patients
with aortic cuffs had less frequent hypertension (56.4% vs
64.4%; P  .0089), and a higher proportion was female
(9.7% vs 6.4%; P  .0384).
Aortic cuffs were more frequently used in patients
with larger aneurysms (61.1 vs 58.0 mm in diameter; P
.0001) and with a shorter (25.4 vs 27.0 mm; P  .0058)
and more angulated (44.0% vs 19.9%; P  .0001) infra-
renal neck (Table II). Iliac limb extensions were also
used in aneurysms with a larger diameter (60.6 vs 58.0
mm; P  .0001). In this group, infrarenal necks were
longer (28.0 vs 27.0 mm; P  .0012) and wider (24.1 vs
23.9 mm; P  .0058) compared with those in patients
without extensions. Aortic cuffs were more frequently
used in AneuRx (7.0%), Lifepath (10.2%), and End-
ologix (36.6%) and less frequently in Zenith (1.4%)
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extensions were more frequently used in AneuRx
(32.5%), Talent (27.0%), and Lifepath (40.2%) and less
frequently in Zenith (14.1%), EVT (1.4%), and End-
ologix (9.8%) devices.
Coexisting common iliac aneurysm was more frequent
Table I. Patient characteristics and risk factors
Variable
Group 1
(controls; n  4932) (proximal
Age, y (range) 72.2 (43-100)† 72
Female sex 315 (6.4%)
ASA class III/III/IV 2411 (48.9%) 1
Unfit for open AAA/general
anesthesia 1224 (24.8%)
SVS-ISCVS risk scores
Diabetes 617 (12.5%)
Smoking 1111 (22.5%)
Hypertension 3175 (64.4%) 1
Hyperlipemia 2146 (43.5%) 1
Cardiac status 2920 (59.2%) 1
Carotid status 865 (17.5%)
Renal status 870 (17.6%)
Pulmonary status 2033 (41.2%)
ASA, American Society of Anesthesiologists; AAA, abdominal aortic a
Cardiovascular Surgery.
*P  .05.
†Mean with range of lowest and highest observation.
Table II. Morphologic characteristics
Measurement
Group 1
(controls;
n  4932)
(p
Proximal neck diameter, mm (range) 23.9 (9-46)†
Proximal neck length, mm (range) 27.0 (2-96)†
Maximum sac diameter, mm (range) 58.0 (40-150)†
Patency of iliac arteries
Aneurysm a. iliaca com. 392 (8.0%)
Occlusion a. iliaca com. 78 (1.6%)
Aneurysm a. hypogastrica 77 (1.6%)
Occlusion a. hypogastrica 253 (5.1%)
Angulation
Aortic neck 980 (19.9%)
Aneurysm 515 (10.4%)
Iliac arteries 1935 (39.2%)
a., arteria; com., communis.
*P  .05.
†Mean with range of lowest and highest observation.
Table III. Early postoperative outcome
Thirty-day rate
Group 1
(controls; n  4932) (proxima
Systemic complications 569 (11.6%)
Rupture of the aneurysm 2 (0.04%)
Conversion to open aortic repair 59 (1.2%)
Mortality 126 (2.6%)
Hospital stay, d (range) 5.7 (0-165)
*P  .05.in patients with iliac device limb extensions (18.8% vs 8.0%;P .0001). In addition, occlusion of the hypogastric artery
during the procedure by stent-graft covering occurred
more frequently in group 3 (10.7% vs 5.1%; P  .0001)
compared with the control group. In group 2, patients also
had more frequent hypogastric device overlapping during
the procedure (8.1% vs 5.1%; P  .0367). Severe angula-
p 2
cuff; n  259) P value
Group 3
(iliac extension; n  1477) P value
2-87)† .1939 72.9 (45-93)† .0037*
.7%) .0384* 82 (5.6%) .2428
3.6%) .0991 759 (51.4%) .0914
7.8%) .2798 412 (27.9%) .0174*
0.4%) .3210 191 (12.9%) .6686
4.3%) .5002 358 (24.2%) .1697
6.4%) .0089* 955 (64.7%) .8422
0.2%) .2879 696 (47.1%) .0143*
3.7%) .0775 902 (61.1%) .2001
5.4%) .3865 256 (17.3%) .8549
4.3%) .1659 310 (21.0%) .0036*
8.2%) .3393 628 (42.5%) .3745
sm; SVS-ISCVS, Society for Vascular Surgery/International Society for
roup 2
al aortic cuff;
 259) P value
Group 3
(iliac extension;
n  1477) P value
(16-38)† .7172 24.1 (14-48)† .0058*
(5-100)† .0058* 28.0 (2-90)† .0012*
(40-100)† .0001* 60.6 (40-172)† .0001*
(8.9%) .5898 278 (18.8%) .0001*
(1.5%) .9628 33 (2.2%) .0916
(3.5%) .0187* 62 (4.2%) .0001*
(8.1%) .0367* 158 (10.7%) .0001*
(44.0%) .0001* 384 (26.0) .0001*
(13.9%) .0783 193 (13.1%) .0048*
(49.0%) .0017* 692 (46.9%) .0001*
oup 2
ic cuff; n  259) P value
Group 3
(iliac extension; n  1477) P value
14.7%) .2855 169 (11.5%) .1850
— .9824 2 (0.14%) .3350
0.8%) .7539 7 (0.5%) .0278*
2.3%) .5513 58 (3.9%) .3437
0-82) .6891 6.0 (0-86) .0001*Grou
aortic
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types of endograft extensions (groups 2 and 3).
The incidence of postoperative systemic morbidity
after EVAR was comparable in all groups of patients. The
hospital stay was longer (6.0 vs 5.7 days; P  .0001) in
group 3 compared with group 1 (Table III). The all-
cause mortality rate was similar in all patient groups.
Aneurysm-related mortality was not higher in patients
with iliac limb extensions than in patients without any
extensions (6.0% vs 4.2% after 4 years; P  .0694; Fig 1).
The use of an aortic cuff or iliac limb extension was not
associated with an increased risk of late rupture of the
aneurysm. Thirty-nine patients experienced a late rup-
ture after a mean of 25.1 months (the 3-year cumulative
rate of rupture was 0.9% in the entire cohort). The late
conversion rate was comparable in the three study
groups (4.9%, 8.9%, and 5.1% after 4 years in groups 1, 2,
and 3, respectively).
Endoleaks, irrespective of type, did not correlate with
the use of any type of endograft extensions. Kinking of the
stent graft was more frequently observed in patients who
had iliac endograft extensions (P  .0344). Secondary
transfemoral interventions were more frequently required
in group 3 than in the control group (P  .0053; Table IV).
The cumulative incidence of transfemoral intervention after
4 years was 8.0%, 11.2%, and 12.6% in groups 1, 2, and 3,
respectively (Fig 2). Stent-graft migration, stenosis, and
thrombosis were not associated with the use of iliac graft
extensions.
DISCUSSION
Among the findings of this study were a substantial
increase in late device kinking and secondary transfemoral
interventions in patients with an iliac device limb extension
during the primary operation. The use of aortic cuffs
yielded a comparable difference from patients without ex-
tensions, although none of these differences reached signif-
Fig 1. Freedom from aneurysm-related mortality. No significant
differences were observed among the three groups.icance, perhaps because of the smaller size of group 2.Endograft extensions were not associated with an increased
incidence of postoperative systemic complications or an
increased 30-day or long-term mortality. These observa-
tions may be reassuring when the use of extensions seems
appropriate.
Some patients in this study required both an aortic
cuff and an iliac limb extension, and this category was
considered in the proximal cuff category. To categorize
the patients in this way was chosen after a preliminary
analysis demonstrated that a number of main outcome
parameters (mortality, device-related complications, and
need for secondary interventions) in patients with both
types of device extensions were closer in agreement with
the group in which aortic cuffs were used than in those
with iliac limb extensions. Because of this, we included
these patients in group 2, in which an aortic cuff was
used. Both groups with endograft extensions included
patients who had multiple device extensions. However,
for practical reasons, we did not further subdivide the
patient categories.
In general, the use of a device extension results in an
additional graft junction, which has the potential to
increase the risk of a type III endoleak.6,7 In this study,
there was a trend toward an increased incidence of type
III endoleaks in patients with endograft extensions.
However, this difference did not reach the level of sig-
nificance in either group 2 or 3. Although there was a
large increase in the incidence of type I endoleaks for
aortic cuffs, this also did not reach statistical significance.
It has been reported previously that type I and III
endoleaks are associated with a significantly increased
risk of aneurysm rupture13,14; this emphasizes the need
for a prompt repair by reintervention, most notably by a
secondary device extension.15
In the long term, the use of iliac endograft extensions
was associated with an increased incidence of secondary
transfemoral procedures. These secondary interventions
were due to the occurrence of an endoleak of either type,
endograft migration, stenosis, or thrombosis. The inci-
dence of each of these different device-related complica-
tions was not related to the use of extensions. The
incidence of device limb kinking was increased in pa-
tients with iliac limb extension. However, device kinking
was not associated with an increased rate of secondary
transfemoral procedures.The all-cause mortality was
similar in all patient groups. Although aneurysm-related
mortality was significantly higher in patients with iliac
limb extensions in univariate analysis, this difference
disappeared in multivariate analysis. AAA diameter, neck
length, patient age, and fitness were all associated with
aneurysm-related mortality in this group of patients.
Device kinking and secondary transfemoral interven-
tions were the only long-term adverse outcomes that were
increased in patients with an iliac graft limb extension. The
same morphologic factors that necessitate the use of iliac
limb extensions may also be responsible for these adverse
effects. Although aortic cuffs demonstrated an influence on
kinking or reintervention similar to that of iliac limb exten-
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of group size and fewer follow-up data. With regard to
treatment cost, extensions and cuffs increase the expense of
the procedure. Having said this, the adverse clinical effects
of endograft extensions seemed quite small, and when the
need arises, they should be used.
Coexisting iliac aneurysm is observed in approxi-
mately 20% to 40% of AAA patients.16-19 These patients
more frequently require distal extension of the en-
dograft. Iliac graft limb extensions were used when the
basic endograft combination was not long enough to
exclude the entire aneurysm or when adequate distal
sealing was not obtained. In this series, 34% of the
patients had some aneurysmal involvement of the iliac
arteries, and of this group, 53% (18% of the total popu-
lation) had extensive aneurysmatic iliac arteries. In 45%
of these cases, an iliac endograft extension was deemed
necessary. The hypogastric artery was understandably
significantly more frequently overlapped and occluded in
patients requiring an endograft extension. In most pa-
tients, the overlapping was combined with a coil embo-
lization to prevent backflow from the hypogastric artery.
Increased anatomic risk in group 3 also included a
larger infrarenal neck and AAA diameter and more angula-
tion of the aortic neck and iliac arteries. It is more difficult
to achieve good attachment of the device in tortuous or
diseased arteries than in patent or healthy arteries. Accord-
ing to Greenberg et al,20 patients at both clinical and
anatomic risk constitute a particularly appropriate indica-
tion for endovascular therapy even when extensions or
additional procedures are necessary. One may conclude
that the use of aortic or iliac graft limb extensions allows
EVAR in aneurysms with a more complex anatomy and
widens the indication for EVAR.
In this series, an aortic cuff or iliac graft limb extension
was used in as many as 35% of the patients during the initial
Table IV. Late adverse events, reinterventions, and morta
Four-year cumulative incidence
Group 1
(controls; n  4932) (proxima
Any endoleak 24.2%
Type I endoleak 8.1%
Type II endoleak 16.5%
Type III endoleak 5.8%
Device migration 7.4%
Stenosis/thrombosis 4.3%
Kinking 1.9%
Aneurysmal growth (8 mm) 12.2%
Any secondary intervention 12.6%
Transfemoral intervention 8.0%
Extra-anatomic intervention 1.3%
Conversion to open repair 4.9%
Rupture of the aneurysm 1.4%
Mortality 23.1%
AAA-related mortality 4.4%
AAA, Abdominal aortic aneurysm.
*P  .05.procedure. Elkouri et al21 performed 9 aortic and 39 iliacextensions in their initial 100 patients. Velazquez et al6
reported a 16% use of aortic cuffs and up to 62% iliac
extensions. Studies regarding endovascular extensions are
limited and mostly concern extensions during secondary
interventions.5,8 However, Biebl et al22 found that proxi-
mal cuffs were an effective intraoperative adjunct to achieve
proximal seal with similar postoperative survival, type I
endoleak rate, and need for secondary interventions com-
pared with patients without proximal aortic cuffs. The only
adverse outcome in the category with aortic cuffs was an
increased incidence of late endograft migration, which
could not be confirmed in the current EUROSTAR study.
Alas, the use of iliac graft limb extensions was not investi-
gated by Biebl et al.22
Weaknesses of this study included a large interobserver
variability and an incomplete dataset, which are commonly
seen in multicenter registries. However, the large number
of patients increased the reliability by reducing the effect of
variability.
The reasons for the use of extensions were not reg-
istered in the EUROSTAR database and could not be
analyzed on a patient-to-patient basis, and this is a
shortcoming of this analysis. It was also impossible to
distinguish between deliberately planned and unplanned
extensions. However, this study enabled us to investigate
statistical associations of the use of device extensions
compared with basic stent-graft combinations. To assess
specific technical queries regarding the use of extensions,
such as fixation and length of overlapping with the
primary stent, additional and more detailed studies will
be more suitable.
In conclusion, despite an increased incidence of device
kinking and secondary interventions in patients treated
with iliac graft extensions, it is encouraging to find that
EVAR with the use of additional extensions provides satis-
factory procedural results. However, single devices are po-
oup 2
ic cuff; n  259) P value
Group 2
(iliac extension; n  1477) P value
.8% .7670 25.9% .2444
.8% .3713 8.1% .8347
.2% .8752 17.4% .3477
.8% .6455 8.8% .1845
.4% .9010 10.2% .0590
.6% .6114 4.2% .1201
.6% .1137 4.7% .0344*
.1% .1636 12.5% .0716
.0% .1823 17.3% .0036*
.2% .5717 12.6% .0053*
.8% .1751 1.9% .7850
.9% .2927 5.1% .9402
.6% .9313 3.0% .0652
.2% .0889 24.9% .1234
.2% .9093 6.0% .0694lity
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cation for them. Extensions may be avoided by accurate
preoperative or intraoperative assessment of the aortoiliac
anatomic configuration.
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Appendix
The EUROSTAR Collaborative centres are:
Austria: Vienna, University Hospital
Belgium: Aalst, General City Hospital; Aalst, Onze
Lieve Vrouwe Hospital; Antwerpen, General Hospital
Middelheim; Antwerpen, St Vincentius Hospital; Antwer-
pen University Hospital; Antwerpen, Monica Hospital/
Onze Lieve Vrouwe/Eeuwfeestkliniek; Antwerpen, St Au-
gustinus Hospital; Assebroek, St Lucas/St Jozef; Aye,
Hospital Princesse Paola; Baudour, Reseau Hospital de
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Volume 45, Number 1 Hobo, Laheij, and Buth 85Medecine Sociale; Bonheiden, Imelda Hospital; Brass-
chaat, General Hospital Klina; Brugge, General Hospital St
Jan; Brussels, Hospital Erasme; Brussels, Academic Hospi-
tal Free University; Brussels, Clinique de l’Europe St
Michel; Brussels, Univeristy Hospital Brugmann; Brussels,
Central Hospital Edith Cavell; Brussels, Hospital d’Iris
Sud; Brussels, University Hospital St Luc; Brussels, Clin-
ique Saint Jean; Charleroi, University Hospital; Dender-
monde, General Hospital St Blasius; Duffel, General Hos-
pital St Maarten; Geel, General Hospital St Dimpna; Genk,
St Jan Hospital; Gent, Volkskliniek; Gent, General Hospi-
tal St Lucas; Gent, St Jan Palfijn; Gent, University Hospital;
Gent, Maria Middelares/St Jozef; Gilly, St Jospeh Hospi-
tal; Haint Saint Paul, Hospital de Jolimont; Halle, Regional
Hospital St Maria; Hasselt, Virga Jesse Hospital; Her-
enthals, St Elisabeth; Ieper, Regional Hospital Jan Yper-
man; Knokke, Gezondheidszorg Oostkust; Kortrijk, Gen-
eral Hospital Groenige; La Louviere, Centre Hospital de
Tivoli; Leuven, University Hospital; Leuven, Heilig Hart;
Liège, University Hospital; Liège, Clinique Saint-Joseph;
Liège-Chenee, Notre-Dame des Bruyeres; Lier, Heilig
Hart; Lommel, Maria Hospital; Malmedy, Clinique Reine
Astrid; Mechelen, Onze Lieve Vrouwe Hospital; Menen,
Heilig Hart; Merksem, Jan Palfijn; Mons, St Joseph War-
quignies; Mont Godinne, De Mont Godinne; Mouscron,
Central Hospital; Namur, Central Hospital; Namur, Clin-
ique St Elisabeth; Ottignies, Clinique Saint-Pierre; Reet,
General Hospital Heilige Familie; Roeselare, Stedelijk
Hospital; Roeselare, Heilig Hart Hospital; Sambreville,
Central Hospital Val de Sambre; St Truiden, St Trudo
Hospital; Tielt, St Andries Hospital; Tournai, Clinique
Notre Dame et St Georges; Turnhout, St Josef Hospital;
Turnhout, St Elisabeth; Veurne, St Augustinus Hospital;
Vilvoorde, St Josef Hospital; Zottegem, General Hospital
St Elisabeth
Denmark: Copenhagen, Rigshospitalet; Odense, Uni-
versity Hospital
France: Draguignan, Hospital Notre Dame; Lyon,
Hospital E Herriot; Paris, Hospital Henri Mondor
Germany: Dusseldorf, Augusta Hospital; Frankfurt,
Städtischen Kliniken; Frankfurt, Cardioangiologisches
Centre Bethanien; Frankfurt, Sankt Katharinen; Hamburg,
Altona General Hospital; Karlsruhe, Klinikum Karlsruhe;
Kempten, Klinikum Kempten; Koblenz, Bundeswehrzen-
tral; Leipzig, Park-Krankenhaus; Marburg, Philipps-Uni-
versity; München, Kliniken Rechts der Isar; Oldenburg,
Pius Hospital; Ulm, University Hospital
Greece: Athens, University Medical School
Ireland: Dublin, St James Hospital
Israel: Tel Aviv, Sheba Medical Centre
Italy: Perugia, PoliclinicoMonteluce; Roma, OspedaleS Giovanni; Varese, Ospedale di Circolo VareseLuxembourg: Luxembourg, Centre Hospitalier
Monaco: Monaco, Centre Cardio-Thoracique
The Netherlands: Alkmaar, Medical Centre; Amster-
dam, Academic Medical Centre; Amsterdam, Free Univer-
sity; Amsterdam, Onze Lieve Vrouwe Gasthuis; Apel-
doorn, Gelre Hospital; Arnhem, Rijnstate; Breda, Amphia
Hospital; Delft, Reinier de Graaf Group; Doetinchem,
SlingerlandHospital; Dordrecht, Albert Schweitzer Hospi-
tal; Eindhoven, Catharina Hospital; Enschede, Medisch
Spectrum Twente; Geldrop, St Anna Hospital; Groningen;
Academic Hospital; Groningen, Martini Hospital; The
Hague, Medical Centre Haaglanden Westeinde; The
Hague, Haga Hospital Leijenburg; Leeuwarden, Medical
Center Leeuwarden;Maastricht, AcademicHospital; Nieu-
wegein, St Antonius Hospital; Nijmegen, Canisius Wil-
helmina Hospital; Nijmegen, Academic Hospital St Rad-
boud; Rotterdam, St Clara Hospital; Rotterdam, Dijkzicht
Hospital; Rotterdam, Franciscus Gasthuis; Tilburg, Elisa-
beth Hospital; Tilburg, Tweesteden Hospital; Utrecht,
University Medical Centre; Veldhoven, St Josef Hospital;
Zwolle, Isala Clinics Sophia
Norway:Oslo, Aker University Hospital; Oslo, Ulleval
Hospital; Trondheim, University Hospital
Poland: Lublin, L’Academie de Medicine; Warsaw,
Medical University; Warsaw, Central Clinical Hospital;
Warsaw, Central Military Hospital
Spain: Barcelona, University Hospital; Barcelona, Ciu-
tat Sanitaria I Universitaria de Bellvitge; Barcelona, Hospi-
tal Santa Creu I S Pau; Donostia San Sebastian, Hospital de
Gipuzkoa; La Coruña, Hospital Juan Canalejo; Leon, Hos-
pital de Leon; Lugo, Hospital Xeral Lugo;Madrid, Univer-
sity Hospital de la Princesa; Madrid, Virgen de la Salud;
Madrid, Hospital Ramon y Cajal; Madrid, Fundacion Jime-
nez Diaz; Madrid, University Hospital of Getafe; Madrid,
Hospital Ruber International; Malaga, Hospital Carlos
Haya; Pamplona, University Hospital of Navarra; Vallado-
lid, Hospital Clinico Valladolid
Sweden: Lund, University Hospital; Örebro, Medical
Centre; Stockholm, Karolinska Hospital
Switzerland: Bern, Clinic for cardiovascular Surgery;
Zürich, Gefasszentrum
Turkey: Ankara, Hacettepe University Faculty of Med-
icine; Istanbul, Memorial Hospital; Istanbul, University
Hospital
United Kingdom: Bournemouth, Royal Hospital;
Bristol, Royal Infermary; Chester, Countess of Chester
Hospital; Glasgow, Gartnavel Hospital; Hull, Royal Infir-
many; Liverpool, Royal University Hospital; Manchester,
Withington Hospital; New Castle-Upon-Tyne, Freeman
Hospital
